Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.28%
1,100.97
-3.13
-0.28%
1,104.101,103.921,108.751,097.16
SIXC
Communications
SIXC
Communications
SIXC
+0.39%
606.54
+2.38
+0.39%
604.16604.16606.88604.12
SIXE
Energy
SIXE
Energy
SIXE
+0.78%
1,207.16
+9.35
+0.78%
1,197.811,200.581,213.071,200.58
SIXI
Industrials
SIXI
Industrials
SIXI
-0.05%
1,739.54
-0.87
-0.05%
1,740.411,739.551,750.271,730.60
SIXM
Financials
SIXM
Financials
SIXM
+0.45%
637.30
+2.86
+0.45%
634.44633.13639.03633.01
SIXR
Staples
SIXR
Staples
SIXR
-0.13%
839.78
-1.12
-0.13%
840.90839.53841.73837.19
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.28%
214.52
-0.61
-0.28%
215.13215.13215.85214.25
SIXT
Technology
SIXT
Technology
SIXT
-0.33%
3,218.17
-10.54
-0.33%
3,228.713,225.623,227.743,198.95
SIXU
Utilities
SIXU
Utilities
SIXU
+0.38%
939.46
+3.59
+0.38%
935.87938.37942.00937.43
SIXV
Health care
SIXV
Health care
SIXV
+0.32%
1,461.73
+4.61
+0.32%
1,457.121,452.741,466.881,449.55
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.86%
2,379.10
-20.74
-0.86%
2,399.842,389.712,392.302,375.49
GLPG:NASDAQ
Galapagos NV - ADR
$28.63
+0.10%
(+0.030) 1D
Apr 27, 10:13:41 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLPG...
Open
$28.46
High
$28.75
Low
$28.44
Mkt. cap
1.88B
Avg. vol.
184.76K
Volume
19.89K
P/E ratio
5.04
52-wk high
$37.78
52-wk low
$24.74
EPS
$5.68
Beta
0.32
Shares outstanding
65.90M
No. of employees
452
News stories
From sources across the web
Profile
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Galapagos NV - ADR
CEOPaul Stoffels | Paul Stoffels
Employees452
Founded1999
Headquarters-
SectorBiotechnology
Websiteglpg.com
Next call in 10 days
Thu, May 7, 8:00 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0.97 est.)EUR
Revenue / Estimate
-/ (24.90M est.)EUR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
74.98M
65.29M
71.16M
900.82M
Cost of goods sold
196.48M
99.98M
84.73M
107.97M
Cost of revenue
196.48M
99.98M
84.73M
107.97M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.80M
30.67M
34.55M
32.29M
Operating expense
37.20M
22.33M
28.10M
170.00K
Total operating expenses
233.68M
122.32M
112.83M
108.14M
Operating income
-158.71M
-57.03M
-41.67M
792.68M
Other non operating income
-8.88M
8.56M
-51.21M
74.15M
EBT including unusual items
-156.37M
-104.42M
-221.49M
783.16M
EBT excluding unusual items
-156.37M
-77.57M
-43.59M
835.73M
Income tax expense
-1.81M
26.00K
-17.50M
666.00K
Effective tax rate
1.16%
-0.02%
7.90%
0.09%
Other operating expenses
-6.59M
-8.34M
-6.44M
-32.12M
Net income
-153.40M
-105.75M
-202.11M
782.15M
Net profit margin
-204.60%
-161.97%
-284.02%
86.83%
Earnings per share
0.97
-0.93
-0.18
12.27
Interest and investment income
12.00M
10.27M
9.91M
14.94M
Interest expense
-780.00K
-
-
-1.03M
Net interest expenses
11.22M
10.27M
9.91M
13.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
-150.26M
-38.77M
-33.23M
800.91M
Gain or loss from assets sale
-
-23.83M
23.83M
-1.06M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more